|
AASDH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98618899105441E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.7494673204842E-12 |
| Normal-vs-Stage2 |
4.25550000000552E-05 |
| Normal-vs-Stage3 |
5.50890000283744E-08 |
| Normal-vs-Stage4 |
1.68587999999081E-05 |
| Stage1-vs-Stage2 |
1.724000E-01 |
| Stage1-vs-Stage3 |
9.879000E-01 |
| Stage1-vs-Stage4 |
9.832000E-01 |
| Stage2-vs-Stage3 |
2.865600E-01 |
| Stage2-vs-Stage4 |
3.941800E-01 |
| Stage3-vs-Stage4 |
9.925800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.60624855030755E-12 |
| Normal-vs-AfricanAmerican |
1.1826000179127E-09 |
| Normal-vs-Asian |
1.676930E-03 |
| Caucasian-vs-AfricanAmerican |
7.676000E-01 |
| Caucasian-vs-Asian |
6.721200E-01 |
| AfricanAmerican-vs-Asian |
7.803600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.9720999999695E-07 |
| Male-vs-Female |
4.860800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.53810014408884E-10 |
| Normal-vs-Extreme_Weight |
2.55173659979846E-12 |
| Normal-vs-Obese |
8.99390006914302E-10 |
| Normal-vs-Extreme_Obese |
1.89868000000093E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.430000E-01 |
| Normal_Weight-vs-Obese |
5.994000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.564400E-01 |
| Extreme_Weight-vs-Obese |
1.466770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.076800E-01 |
| Obese-vs-Extreme_Obese |
7.171400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.554900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.43749489878564E-11 |
| Normal-vs-Age(61-80Yrs) |
1.91402449445377E-13 |
| Normal-vs-Age(81-100Yrs) |
1.91629999646281E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.362400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.021500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.196400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.155000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.537400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.571400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62492241884138E-12 |
| Normal-VS-Type2 PRCC |
7.00229874084357E-11 |
| Normal-VS-KIRP CIMP |
2.532400E-02 |
| Normal-VS-Unclassified PRCC |
4.86180000003333E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.972000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.714600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.625360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.693000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.859240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.471200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.9773072068574E-13 |
| Normal-vs-N1 |
1.000990E-04 |
| Normal-vs-N2 |
8.41940000000374E-05 |
| N0-vs-N1 |
2.929800E-01 |
| N0-vs-N2 |
4.426400E-01 |
| N1-vs-N2 |
3.501200E-01 |
|
|
